Tag Archive for: Long COVID

The results, published Friday in JAMA Internal Medicine, showed that at 10 weeks, Paxlovid did not significantly lower the severity of the six core symptoms of long COVID, compared with patients who were treated with placebo and ritonavir.

Tonix Pharmaceuticals Holding Corp. said on Tuesday its experimental drug failed to meet the primary goal in a mid-stage study for management of widespread muscle pain and tenderness associated with long COVID-19.

Japan’s Shionogi & Co. Ltd. believes its COVID-19 pill will easily garner $2 billion in annual sales if it secures U.S. approval, which the company expects to receive in late 2024, its chief executive said.

Three years later, at least 65 million people worldwide are estimated to have long COVID, according to an evidence review published last month in Nature Reviews Microbiology. More than 200 symptoms have been linked to the syndrome – including extreme fatigue, difficulty thinking, headaches, dizziness when standing, sleep problems, chest pain, blood clots, immune dysregulation, and even diabetes.

In a strategic reorganization announced Thursday, Axcella Therapeutics will focus its resources on its Long COVID program and slash headcount by 85%.

The U.S. National Institutes of Health’s $1 billion RECOVER Initiative has picked Pfizer Inc.’s antiviral drug Paxlovid as the first treatment it will study in patients with long COVID, organizers of the study said on Thursday.

Researchers chasing long COVID cures are eager to learn whether naltrexone, a generic drug typically used to treat alcohol and opioid addiction, can offer benefits to millions suffering from pain, fatigue and brain fog months after a coronavirus infection.

The proportion of Britain’s workforce too sick to work has jumped to its highest since 2005, which economists say is likely due to a mix of long COVID and greater difficulty in accessing health care since the start of the pandemic.

There is no authoritative data on the frequency of suicides among sufferers. Several scientists from organizations including the U.S. National Institutes of Health and Britain’s data-collection agency are beginning to study a potential link following evidence of increased cases of depression and suicidal thoughts among people with long COVID, as well as a growing number of known deaths.

Top scientists from leading academic centers are banding together to answer a key question about the root cause of long COVID – whether fragments of the coronavirus persist in the tissues of some individuals.